Ping An Biomedical Co., Ltd 6-K, filed Sep 15, 2025
Ping An Biomedical Co., Ltd. (PASW)
About this 6-K
Ping An Biomedical Co., Ltd filed this 6-K on September 15, 2025.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September, 2025
Commission File Number: 001-42155
| Majestic Ideal Holdings Ltd | ||
| (Registrant’s Name) |
22/F, China United Plaza, 1002-1008, Tai Nan West Street,
Cheung Sha Wan, Kowloon, Hong Kong
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Submission of Matters to a Vote of Security Holders
On September 12, 2025 Majestic Ideal Holdings Ltd (the “Company”) held the Company’s Extraordinary General Meeting (the “EGM”) at 11:00 a.m. (Hong Kong time and date) at 7/F, China United Plaza, 1002-1008, Tai Nan West Street, Cheung Sha Wan, Kowloon, Hong Kong. On August 22, 2025 (the “Record Date”), the record date for the EGM, there were 20,500,000 of the Company’s Ordinary Shares outstanding and entitled to vote at the EGM. 14,297,969 Ordinary Shares, which represented 69.57% of the shares of the outstanding Ordinary Shares in the Company, were represented in person or by proxy.
Two items of business were acted upon by the Company’s shareholders at the EGM, each of which was approved by the shareholders as a special resolution:
| 1. | “That: |
| (a) | Subject to and conditional upon the approval of the Registrar of Companies in the Cayman Islands, the Company’s English company name be changed from “Majestic Ideal Holdings Ltd” to “Ping An Biomedical Co., Ltd.” and its dual foreign name in Chinese be changed from “威美控股有限公司” to “平安生物医药有限公司” (“Proposed Change of Company Name”) with effect from the date of entry of the new English name and the dual foreign name in Chinese of the Company on the register maintained by the Registrar of Companies in the Cayman Islands and the date on which the certificate of incorporation on change of name is issued by the Registrar of Companies in the Cayman Islands; and |
| 2. | “That: |
| (a) | any one director, the secretary, and/or the registered office provider of the Company be instructed to notify the Registrar of Companies in the Cayman Islands of any special resolution so passed, to make any necessary filings in relation thereto, and to do all such acts and things and execute all such documents as he/she/they consider necessary, desirable or expedient for the purpose of, or in connection with, the implementation of and giving effect to the Proposed Change of Company Name. |
The voting results were as follows:
| For | Against | Abstain | ||||||||||
| Proposal 1 | 14,297,631 | 66 | 272 | |||||||||
| Proposal 2 | 14,297,859 | 66 | 44 | |||||||||
Exhibits.
The following exhibits are being filed herewith:
| Exhibit No. | Description | |
| 99.1* | Press Release |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| MAJESTIC IDEAL HOLDINGS LTD | ||
| By: | /s/ Yuk Yin Judy Li | |
| Name: | Yuk Yin Judy Li | |
| Title: | Chairperson of the Board of Directors | |
Date: September 15, 2025
2
Exhibit 99.1
Press Release
Majestic Ideal Holdings Ltd Announces Approval of Name Change to “Ping An Biomedical Co., Ltd.” at Extraordinary General Meeting
Hong Kong, September 12, 2025 — Majestic Ideal Holdings Ltd (NASDAQ: MJID) (the “Company”) announced that during the Extraordinary General Meeting of Shareholders (the “Meeting”) held today at 11:00 a.m. at the Company’s office located at 7/F, China United Plaza, 1002-1008, Tai Nan West Street, Cheung Sha Wan, Kowloon, Hong Kong, the proposal to change the Company’s name was officially approved subject to and conditional upon the approval of the Registrar of Companies in the Cayman Islands.
The Meeting was duly convened, and Ms. Yuk Yin Judy Li, acting as the Chairperson of the Meeting in accordance with the Company’s Articles of Association, declared the Meeting open and confirmed that the quorum requirement was met.
Resolutions Passed
The Meeting deliberated and unanimously approved the following special resolutions:
Change of Company Name
The Company’s English name will be changed from “Majestic Ideal Holdings Ltd” to “Ping An Biomedical Co., Ltd.”
The Company’s Chinese name will be changed from “威美控股有限公司” to “平安生物医药有限公司”.
The name change will take effect upon the date of entry of the new English name and the dual foreign name in Chinese of the Company on the register maintained by the Registrar of Companies in the Cayman Islands and the date on which the certificate of incorporation on change of name is issued by the Registrar of Companies in the Cayman Islands.
Authorization to Implement Name Change
The Meeting authorized any one director, the secretary, and/or the registered office provider of the Company to notify the Cayman Islands Registrar of Companies of the special resolutions, complete all necessary filings, and take any actions required to implement the name change.
Both special resolutions were approved by a majority of at least two-thirds of shareholders being entitled to vote and present in person or by proxy at the Meeting.
Company Statement
The Board of Directors believes that the approved name change will enhance the Company’s corporate image and align with its strategic focus on biomedical and healthcare technologies. The Company remains committed to driving innovation and positioning itself as a leader in the industry.
About Majestic Ideal Holdings Ltd
Majestic Ideal Holdings Ltd is a one-stop SCM service provider in the apparel industry. It is also a forward-thinking company dedicated to delivering innovative solutions in healthcare and biomedical technology. The proposed name change reflects its commitment to advancing its mission and positioning itself as a leader in the industry.
For more information, please contact:
Celestia Investor Relations
Email: investors@celestiair.com